+905423212512 24/7 patient support
English
EUR
Oncology

Cervical Cancer Treatment in Turkey

Cervical cancer is a malignancy originating in the cells lining the cervix, the lower part of the womb. Women often contact a doctor following abnormal vaginal bleeding, unusual discharge, or pelvic discomfort, though early stages may produce no noticeable signs. The available treatment options depend on a specialist assessment and detailed staging investigations. Compare hospitals in Turkey that treat Cervical Cancer and get a free review of your medical records.

3 min read

Cervical Cancer Treatment in Turkey
Price from
Price on request
Clinics
2
Treated with
4

Verified surgeons for Cervical Cancer

1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.

About Cervical Cancer

Cervical cancer is a malignancy originating in the cells lining the cervix, the lower part of the womb. Women often contact a doctor following abnormal vaginal bleeding, unusual discharge, or pelvic discomfort, though early stages may produce no noticeable signs. The available treatment options depend on a specialist assessment and detailed staging investigations.

Specialty: Oncology

Treatment options

Depending on the stage and your medical history, doctors may recommend:

Best Clinics for Cervical Cancer Treatment in Turkey

Frequently asked questions

The cost of treating Cervical Cancer depends on the diagnosis and the treatment chosen. Doctors first review your medical records — free of charge — and you then receive an itemised quote.

Options may include Radiotherapy for Cervical Cancer, Chemotherapy for Cervical Cancer, Complex Diagnostics of Cervical Cancer, Brachytherapy for Cervical Cancer. Your doctor chooses the approach after reviewing your tests and scans.

Cervical Cancer is treated by Oncology specialists. 2 clinics in Turkey on our platform offer this treatment.

What Is Cervical Cancer and What Are Its Symptoms?

Cervical cancer arises in the cells lining the cervix, the lower segment of the uterus opening into the vagina. Persistent infection with high-risk human papillomavirus (HPV) strains, particularly HPV-16 and HPV-18, causes the vast majority of cases. Most tumours originate as squamous cell carcinomas in the transformation zone, while a smaller proportion develop as adenocarcinomas in glandular cells.

Early-stage cervical neoplasia often develops without noticeable warning signs. As malignant cells invade deeper cervical stroma, symptoms emerge. Patients visiting a specialist in gynaecology commonly report:

  • Abnormal vaginal bleeding: Bleeding between menstrual periods, post-coital spotting, or postmenopausal bleeding.
  • Atypical discharge: Watery, pink, or foul-smelling vaginal discharge that does not resolve with routine treatments.
  • Pelvic discomfort: Persistent pain in the lower abdomen, pelvis, or lower back, often worsening during intercourse.
  • Urinary or bowel disruption: Advanced local tumours may press against surrounding pelvic organs, producing painful urination or bowel changes.

How Cervical Cancer Is Diagnosed and Staged

Accurate staging guides all oncological decision-making. When you arrive at a hospital in Turkey, multidisciplinary teams evaluate tumour size, depth of stromal invasion, parametrial involvement, and lymph node status using the FIGO (International Federation of Gynaecology and Obstetrics) system.

Clinical evaluation relies on comprehensive check-ups and diagnostics to determine cancer spread. Hospital evaluations typically include:

  • Colposcopy and biopsy: Magnified cervical examination and targeted tissue sampling via punch biopsy, loop electrosurgical excision (LEEP), or conisation.
  • Pathology slide review: Expert review of external biopsy blocks and glass slides to confirm histological type, tumour grade, and lymphovascular space invasion.
  • Pelvic MRI: High-resolution imaging to measure tumour volume and evaluate stromal, vaginal, or parametrial invasion.
  • PET-CT or chest-abdomen CT: Whole-body scanning to detect metastases in pelvic or para-aortic lymph nodes and distant organs.
  • Endoscopy: Selective cystoscopy or sigmoidoscopy if bladder or rectal infiltration is suspected.

Patients should bring their original pathology reports, paraffin-embedded tissue blocks or unstained glass slides, previous pelvic imaging on CD or DICOM format, and relevant surgical or screening summaries.

Treatment Options for Cervical Cancer

Therapeutic strategies depend on disease stage, histological characteristics, general health, and whether you wish to preserve fertility. Clinical decisions are made by treating doctors in specialised oncology units following diagnostic verification.

OptionTypically used whenThings to know
Fertility-sparing surgeryMicroscopic or small early-stage tumours (FIGO IA to small IB1) without lymph node spread.Procedures like conisation or radical trachelectomy remove malignant tissue while preserving the womb. Often planned alongside IVF and fertility specialists.
Radical hysterectomyEarly-stage disease (FIGO IA2 to IB2) when fertility preservation is not needed.Removes the uterus, cervix, parametrium, upper vagina, and pelvic lymph nodes. Requires surgical hospitalisation and recovery.
Chemoradiotherapy (CCRT)Locally advanced tumours (FIGO IB3 to IVA) or high-risk post-surgical pathology.Combines external beam radiation with weekly cisplatin chemotherapy, followed by brachytherapy (internal radiation) directed at the tumour site.
Systemic therapyMetastatic (FIGO IVB) or recurrent cancer unsuitable for local treatments.Uses platinum chemotherapy regimens, often combined with targeted therapies or immunotherapy, to manage symptoms and halt tumour progression.

Following primary treatment, specialised rehabilitation helps address pelvic floor recovery, sexual health adjustments, and lower-limb lymphedema prevention.

Planning Your Medical Journey to Turkey

Organising oncological treatment abroad requires careful planning. Before travel, international hospital coordination teams review your diagnostic reports and medical history to provide a provisional clinical roadmap.

Your length of stay in Turkey depends on the recommended treatment modality:

  • Surgical management: Surgical patients generally need 10 to 18 days in Turkey to accommodate pre-operative fitness checks, the hospital procedure, drain or catheter removal, and surgical wound review.
  • Chemoradiotherapy: Daily external radiation combined with weekly chemotherapy and subsequent brachytherapy requires a continuous stay of five to seven weeks.
  • Diagnostic reassessment and systemic therapy: Diagnostic workups or starting a chemotherapy cycle usually require 5 to 10 days, with options for shared care with your home doctor.

Before flying home, your hospital provides full discharge summaries, surgical records, radiation dose plans, and pathology reports. Establishing clear communication between your Turkish care team and your local oncologist ensures smooth ongoing surveillance and timely management of any delayed side effects.

When Travel Is Not Advisable and Urgent Warning Signs

Air travel places physiological strain on the body, increasing dehydration and the risk of venous thromboembolism. Certain acute symptoms make long-distance transit unsafe.

Do not travel, and seek immediate emergency care locally, if you develop:

  • Heavy vaginal haemorrhage: Sudden, severe bleeding with large clots, accompanied by dizziness, faintness, or pallor.
  • Severe pelvic infection: High fever, chills, severe abdominal pain, or foul purulent discharge indicating pelvic inflammatory disease or abscess.
  • Urinary obstruction: Acute severe flank pain or sharply reduced urine output, which may indicate ureteral blockage requiring urgent local stenting.
  • Suspected blood clots: Sudden breathlessness, chest pain, coughing blood, or unexplained calf swelling and warmth.
  • Intractable pain or bowel obstruction: Severe nausea, continuous vomiting, or persistent abdominal distension that prevents oral intake.

Your treating physician must assess your individual medical stability and confirm fitness to fly before any international travel takes place.

Frequently asked questions

Fertility-sparing options, such as a conisation or radical trachelectomy, may be considered for small, early-stage tumours when cancer has not spread to the parametrium or lymph nodes. The cervix and upper vagina are removed while the body of the uterus is preserved. Your oncologist and gynaecological surgeon determine suitability after reviewing detailed pelvic MRI scans and histological margins.

Surgery is primarily utilised for early-stage cervical cancer where the tumour is confined to the cervix. For locally advanced tumours that have spread into surrounding tissues or pelvic lymph nodes, definitive chemoradiotherapy is standard. This treatment combines external radiation and low-dose chemotherapy with brachytherapy, delivering concentrated radiation directly to the tumour while sparing healthy surrounding pelvic structures.

You should bring your original histopathology report, formal biopsy review documents, and physical paraffin tissue blocks or unstained glass slides for laboratory verification. Additionally, bring digital copies of all pelvic MRI, CT, or PET-CT scans on disc, alongside medical notes detailing past gynaecological surgeries or screening results. Having original materials prevents diagnostic delays and unnecessary repeat procedures.

The length of your stay depends on the chosen treatment approach. Patients undergoing surgical treatment typically stay in Turkey for 10 to 18 days to complete pre-operative preparation, surgery, and post-operative monitoring. If your medical team recommends definitive concurrent chemoradiotherapy, expect to stay for five to seven weeks to complete daily external beam radiation sessions alongside brachytherapy treatments.

Before you leave Turkey, your medical team provides detailed clinical documentation, including operative reports, radiation plans, and imaging discs. You will share these records with your oncologist or gynaecologist at home to continue scheduled surveillance. Follow-up visits usually occur every three to four months for the first two years, incorporating physical examinations, pelvic checks, and periodic imaging.

Free personalised quote